EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Embecta Corp.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.21−0.06 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $363.36M
- P/E (TTM)
- 4.2
- Dividend yield
- 9.66%
Embecta statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Embecta | Industry median |
|---|---|---|
| Market Cap | $351.86M | $229.23M |
| Enterprise Value | $1.59B | $194.73M |
| PE Ratio | 4.22 | 33.41 |
| PS Ratio | 0.35 | 3.14 |
| P/FCF Ratio | 2.14 | 27.25 |
| P/OCF Ratio | 2.02 | 22.23 |
Enterprise value
| Measure | Embecta | Industry median |
|---|---|---|
| EV / Sales | 1.56 | 2.93 |
| EV / EBITDA | 5.95 | 19.97 |
| EV / EBIT | 7.12 | 25.47 |
| EV / FCF | 9.67 | 27.85 |
Income (trailing twelve months)
| Measure | Embecta | Industry median |
|---|---|---|
| Revenue | $1.02B | $102.39M |
| Gross Profit | $601.30M | $60.36M |
| Operating Income | $223.50M | -$4.31M |
| Pretax Income | $125.00M | -$2.26M |
| Net Income | $87.50M | -$6.57M |
| EBITDA | $267.70M | -$1.98M |
| EPS (Diluted) | $1.47 | -$0.07 |
Margins
| Measure | Embecta | Industry median |
|---|---|---|
| Gross Margin | 59.0% | 55.1% |
| Operating Margin | 21.9% | -6.04% |
| Pretax Margin | 12.3% | -4.11% |
| Profit Margin | 8.59% | -10.5% |
| EBITDA Margin | 26.3% | -2.67% |
| FCF Margin | 16.2% | -0.30% |
Returns
| Measure | Embecta | Industry median |
|---|---|---|
| Return on Assets (ROA) | 7.22% | -13.3% |
| Return on Invested Capital (ROIC) | 26.2% | -4.11% |
| Return on Capital Employed (ROCE) | 26.4% | -9.07% |
Growth
| Measure | Embecta | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -7.60% | 8.85% |
| Net Income Growth (YoY) | 4.67% | 10.6% |
| EPS Growth (YoY) | 2.80% | 10.6% |
| FCF Growth (YoY) | 24.4% | 10.6% |
| Revenue Growth (3Y CAGR) | -1.47% | 7.08% |
| Revenue Growth (5Y CAGR) | -0.09% | 11.8% |
| EPS Growth (3Y CAGR) | -25.3% | 3.06% |
| EPS Growth (5Y CAGR) | -26.4% | 7.64% |
Balance sheet
| Measure | Embecta | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $214.70M | $37.33M |
| Total Debt | $1.46B | $72.66M |
| Net Cash (Debt) | -$1.24B | $3.92M |
| Net Cash Per Share | -$21.89 | $0.28 |
| Equity (Book Value) | -$612.70M | $57.36M |
| Book Value Per Share | -$10.81 | $2.81 |
| Tangible Book Value | -$700.10M | $10.71M |
| Working Capital | $285.30M | $54.64M |
Financial position
| Measure | Embecta | Industry median |
|---|---|---|
| Current Ratio | 1.68 | 2.50 |
| Quick Ratio | 0.95 | 1.54 |
| Debt / EBITDA | 5.44 | 2.31 |
| Debt / FCF | 8.84 | 3.50 |
| Net Debt / EBITDA | 4.63 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Embecta | Industry median |
|---|---|---|
| Operating Cash Flow | $174.10M | -$653.46K |
| Capital Expenditures | -$9.50M | -$3.69M |
| Free Cash Flow | $164.60M | -$835.02K |
| FCF Per Share | $2.91 | -$0.02 |
Efficiency
| Measure | Embecta | Industry median |
|---|---|---|
| Asset Turnover | 0.84 | 0.59 |
| Inventory Turnover | 2.07 | 2.21 |
| Revenue Per Employee | $550.65K | $322.75K |
| Profits Per Employee | $47.30K | -$52.11K |
| Employee Count | 1,850 | 197 |
Dividends and yields
| Measure | Embecta | Industry median |
|---|---|---|
| Earnings Yield | 24.9% | -6.92% |
| FCF Yield | 46.8% | -0.62% |
| Dividend Yield | 9.66% | 0.81% |
| Shareholder Yield | 9.66% | 0.84% |
| Dividend Per Share | $0.60 | $0.72 |
| Dividend Growth (YoY) | 0.00% | 4.80% |
| Years of Dividend Growth | 0 | 0 |
| Payout Ratio | 31.1% | 30.3% |
| FCF Payout Ratio | 16.5% | 21.9% |
Shares
| Measure | Embecta | Industry median |
|---|---|---|
| Shares Outstanding | 56,659,600 | 44,856,700 |
| Shares Change (YoY) | 0.88% | 3.35% |
| Shares Change (QoQ) | -4.50% | 0.27% |
| Float | 54,467,300 | 36,934,400 |
| Shares Held by Insiders | 3.87% | 10.6% |
| Shares Held by Institutions | 88.9% | 63.5% |
Taxes
| Measure | Embecta | Industry median |
|---|---|---|
| Income Tax | $37.50M | $1.52M |
| Effective Tax Rate | 30.0% | 18.6% |
Scores
| Measure | Embecta | Industry median |
|---|---|---|
| Altman Z-Score | 1.32 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.11 | -2.64 |
Calculated by StockData from Embecta's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.